Depressive symptoms and SSRI use in pediatric oncology patients

Pediatric Blood and Cancer

Volumn 49, Issue 7, 2007, Pages 881-887

  Kersun, Leslie S ^a,b   Elia, Josephine ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer; Depression; Pediatric; SSRI

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CITALOPRAM; CYPROHEPTADINE; FLUOXETINE; KETANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VENLAFAXINE;

AGITATION; ANTICHOLINERGIC SYNDROME; ANXIETY DISORDER; CANCER PATIENT; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL TRIAL; COMA; CONFUSION; CONSTIPATION; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG METABOLISM; DRUG TOLERABILITY; FEVER; GASTROINTESTINAL TOXICITY; HALLUCINATION; HEADACHE; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPERTHERMIA; INSOMNIA; NAUSEA; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SEIZURE THRESHOLD; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SUICIDE; SWEATING; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPNEA; VOMITING; WEIGHT GAIN;

ANXIETY DISORDERS; DEPRESSIVE DISORDER; HUMANS; NEOPLASMS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 35648992914     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21208     Document Type: Review

References (61)

1. Supportive Care of Children With Cancer. Altman AJ, editor. Baltimore: The Johns Hopkins University Press; 2004. 412 p.
2. Suris JC, Parera N, Puig C. Chronic illness and emotional distress in adolescence. J Adolesc Health 1996;19:153-156.
3. Allen R, Newman SP, Souhami RL. Anxiety and depression in adolescent cancer: Findings in patients and parents at the time of diagnosis. Eur J Cancer 1997;33:1250-1255.
4. Noll RB, Gartstein MA, Vannatta K, et al. Social, emotional, and behavioral functioning of children with cancer. Pediatrics 1999;103:71-78.
5. von Essen L, Enskar K, Kreuger A, et al. Self-esteem, depression and anxiety among Swedish children and adolescents on and off cancer treatment. Acta Paediatr 2000;89:229-236.
6. Shemesh E, Bartell A, Newcorn JH. Assessment and treatment of depression in medically ill children. Curr Psychiatry Rep 2002;4:88-92.
7. Shemesh E. Non-adherence to medications following pediatric liver transplantation. Pediatr Transplant 2004;8:600-605.
8. Recklitis CJ, Lockwood RA, Rothwell MA, et al. Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol 2006;24:3852-3857.
9. Kennard B, Stewart S, Olvera R, et al. Nonadherence in adolescent oncology patients: Preliminary data on psychological risk factors and relationship to outcome. J. Clin. Psychol. Med. Settings 2004;11:31-39.
10. Relling MV, Hancock ML, Boyett JM, et al. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 1999;93:2817-2823.
11. Fergusson DM, Woodward LJ. Mental health, educational, and social role outcomes of adolescents with depression. Arch Gen Psychiatry 2002;59:225-231.
12. Shemesh E, Annunziato RA, Shneider BL, et al. Parents and clinicians underestimate distress and depression in children who had a transplant. Pediatr Transplant 2005;9:673-679.
13. Reuter K, Harter M. The concepts of fatigue and depression in cancer. Eur J Cancer Care (Engl) 2004;13:127-134.
14. Harris ES, Canning RD, Kelleher KJ. A comparison of measures of adjustment, symptoms, and impairment among children with chronic medical conditions. J Am Acad Child Adolesc Psychiatry 1996;35:1025-1032.
15. Shemesh E, Yehuda R, Rockmore L, et al. Assessment of depression in medically ill children presenting to pediatric specialty clinics. J Am Acad Child Adolesc Psychiatry 2005;44:1249-1257.
16. Hedstrom M, Kreuger A, Ljungman G, et al. Accuracy of assessment of distress, anxiety, and depression by physicians and nurses in adolescents recently diagnosed with cancer. Pediatr Blood Cancer 2006;46:773-779.
17. Fallowfield L, Jenkins V, Farewell V, et al. Efficacy of a cancer research UK communication skills training model for oncologists: A randomised controlled trial. Lancet 2002;359:650-656.
18. Foley DL, Goldston DB, Costello EJ, et al. Proximal psychiatric risk factors for suicidality in youth: The great smoky mountains study. Arch Gen Psychiatry 2006;63:1017-1024.
19. King CA, Knox MS, Henninger N, et al. Major depressive disorder in adolescents: Family psychiatric history predicts severe behavioral disinhibition. J Affect Disord 2006;90:111-121.
20. Appleton PL, Ellis NC, Minchom PE, et al. Depressive symptoms and self-concept in young people with spina bifida. J Pediatr Psychol 1997;22:707-722.
21. Ritchie MA. Self-esteem and hopefulness in adolescents with cancer. J Pediatr Nurs 2001;16:35-42.
22. Harter S. Self and identity development, In: Feldman S, Elliot G, editors. At the threshold: The developing adolescent. Cambridge: Harvard University Press; 1993.
23. Frank NC, Blount RL, Brown RT. Attributions, coping, and adjustment in children with cancer. J Pediatr Psychol 1997;22:563-576.
24. Varni JW, Katz E. Stress, social support and negative affectivity in children with newly diagnosed cancer: A prospective transactional analysis. Psychooncology 1997;6:267-278.
25. Last BF, van Veldhuizen AM. Information about diagnosis and prognosis related to anxiety and depression in children with cancer aged 8-16 years. Eur J Cancer 1996;32:290-294.
26. Costello EJ, Angold A, Burns BJ, et al. The great smoky mountains study of youth. Functional impairment and serious emotional disturbance. Arch Gen Psychiatry 1996;53:1137-1143.
27. Garrison CZ, Waller JL, Cuffe SP, et al. Incidence of major depressive disorder and dysthymia in young adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:458-465.
28. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety 1998;7:3-14.
29. Michalowski M, Ketzer C, Daudt L, et al. Emotional and behavioral symptoms in children with acute leukemia. Haematologica 2001;86:821-826.
30. Chao CC, Chen SH, Wang CY, et al. Psychosocial adjustment among pediatric cancer patients and their parents. Psychiatry Clin Neurosci 2003;57:75-81.
31. Dunitz M, Scheer PJ, Wurst L, et al. Depression in children with cancer. Padiatr Padol 1991;26:267-270.
32. Mulhern RK, Fairclough DL, Smith B, et al. Maternal depression, assessment methods, and physical symptoms affect estimates of depressive symptomatology among children with cancer. J Pediatr Psychol 1992;17:313-326.
33. Worchel FF, Rae WA, Olson TK, et al. Selective responsiveness of chronically ill children to assessments of depression. J Pers Assess 1992;59:605-615.
34. Challinor JM, Miaskowski CA, Franck LS, et al. Somatization, anxiety and depression as measures of health-related quality of life of children/adolescents with cancer. Int J Cancer Suppl 1999;12:52-57.
35. Canning EH, Canning RD, Boyce WT. Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatry 1992;31:1120-1124.
36. Cavusoglu H. Depression in children with cancer. J Pediatr Nurs 2001;16:380-385.
37. Schoenherr S, Brown RT, Baldwin K, et al. Attributional styles and psychopathology in pediatric chronic-illness groups. J Clin Child Psychol 1992;21:380-387.
38. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychol Bull 2006;132:132-149.
39. Kersun LS, Kazak AE. Prescribing practices of selective serotonin reuptake inhibitors (SSRIs) among pediatric oncologists: A single institution experience. Pediatr Blood Cancer 2005.
40. Portteus A, Ahmad N, Tobey D, Leavey P. The prevalence and use of antidepressant medication in pediatric cancer patients. J Child Adolec Psychopharmacol 2006;16:467-473.
41. Gothelf D, Rubinstein M, Shemesh E, et al. Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. J Am Acad Child Adolesc Psychiatry 2005;44:1258-1262.
42. Kazak AE, Simms S, Rourke MT. Family systems practice in pediatric psychology. J Pediatr Psychol 2002;27:133-143.
43. Hazell P. Depression in children and adolescents. Clin Evid 2004:427-442.
44. Biederman J. Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry 1991;30:495-498.
45. Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993;32:792-797.
46. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-1215.
47. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. Jama 2004;292:807-820.
48. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. Jama 2003;290:1033-1041.
49. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-772.
50. Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 2004;363:1341-1345.
51. Cheung AH, Emslie GJ, Mayes TL. The use of antidepressants to treat depression in children and adolescents. CMAJ 2006;174:193-200.
52. Portteus A, Ahmad N, Tobey D, et al. The prevalence and use of antidepressant Medication in pediatric cancer patients. J Child Adolesc Psychopharmacol 2006;16:467-473.
53. Leonard HL, March J, Rickler KC, et al. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:725-736.
54. Scharko AM, Reiner WG. Ssri-induced sexual dysfunction in adolescents. J Am Acad Child Adolesc Psychiatry 2004;43:1067-1068.
55. Maina G, Albert U, Salvi V, et al. Weight gain during long-term treatment of obsessive-compulsive disorder: A prospective comparison between serotonin reuptake inhibitors. J Clin Psychiatry 2004;65:1365-1371.
56. Prasher VP. Seizures associated with fluoxetine therapy. Seizure 1993;2:315-317.
57. Mills KC. Serotonin syndrome. A clinical update. Crit Care Clin 1997;13:763-783.
58. Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: Implications for diagnosis and treatment. Clin Neuropharmacol 2005;28:205-214.
59. Mosholder A. Food and Drag Administration Psychopharmacologic Drugs Advisory Committee Web site (http://www.fda.gov), Volume 2005; 2005.
60. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-339.
61. Relling MV, Cherrie J, Schell MJ, et al. Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects. Clin Pharmacol Ther 1991;50:308-313.